Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
headphones
The Lancet Neurology in conversation with

The Lancet Neurology in conversation with

The Lancet Group

Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.

bookmark
Share icon

All episodes

Best episodes

Top 10 The Lancet Neurology in conversation with Episodes

Goodpods has curated a list of the 10 best The Lancet Neurology in conversation with episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to The Lancet Neurology in conversation with for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite The Lancet Neurology in conversation with episode by adding your comments to the episode page.

The Lancet Neurology in conversation with - TDP-43 and Alzheimer's disease: The Lancet Neurology: November 2017
play

10/11/17 • 9 min

Keith Josephs talks about considering TDP-43 as a potential factor related to increased rates of hippocampal atrophy in patients with Alzheimer's disease.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

bookmark
plus icon
share episode
The Lancet Neurology in conversation with - Biomarkers in stroke recovery: The Lancet Neurology: October 2017
play

09/13/17 • 7 min

Cathy Stinear discusses her review of biomarkers that might predict motor recovery after stroke.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

bookmark
plus icon
share episode
The Lancet Neurology in conversation with - Genetic variants and Huntington's: The Lancet Neurology: September 2017
play

08/09/17 • 18 min

Lesley Jones and Sarah Tabrizi talk about their work on the identification of genetic markers associated with the progression of Huntington's disease.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

bookmark
plus icon
share episode
The Lancet Neurology in conversation with - Simvastatin and MS: The Lancet Neurology: August 2017

Simvastatin and MS: The Lancet Neurology: August 2017

The Lancet Neurology in conversation with

play

07/12/17 • 4 min

Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

bookmark
plus icon
share episode
The Lancet Neurology in conversation with - Progressive supranuclear palsy: The Lancet Neurology: July 2017
play

06/14/17 • 24 min

Adam Boxer offers an overview of the latest on diagnosis and treatment for progressive supranuclear palsy.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

bookmark
plus icon
share episode
The Lancet Neurology in conversation with - Neurological consequences of obesity: The Lancet Neurology: May 9, 2017
play

05/09/17 • 9 min

Eva Feldman discusses the neurological consequences of obesity.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

bookmark
plus icon
share episode
The Lancet Neurology in conversation with - Neurodegenerative disease: The Lancet Neurology: February 23, 2017
play

02/24/17 • 21 min

Marc Diamond discusses his Personal View on the prion model for progression and diversity of neurodegenerative diseases.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

bookmark
plus icon
share episode
The Lancet Neurology in conversation with - Autosomal dominant familial Alzheimer's disease: The Lancet Neurology: 21 October 2016
play

10/22/16 • 21 min

Randall Bateman and Nick Fox discuss what they've learned from their papers on Alzheimer's disease.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

bookmark
plus icon
share episode
The Lancet Neurology in conversation with - Ventilation for ALS patients: The Lancet Neurology: November 2016
play

10/12/16 • 9 min

Professor Thomas Similowski discusses his surprising study on the effectiveness of non-invasive ventilation for patients with amyotrophic lateral sclerosis.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

bookmark
plus icon
share episode
The Lancet Neurology in conversation with - Suvankar Pal on the motor neuron disease trial MND-SMART

Suvankar Pal on the motor neuron disease trial MND-SMART

The Lancet Neurology in conversation with

play

10/16/24 • 17 min

Professor Suvankar Pal (University of Edinburgh) joins Sarah Passey (Senior Editor at The Lancet Neurology) to discuss the first findings from the MND-SMART trial of treatments for motor neuron disease. The Article is published in the November issue of The Lancet Neurology.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

bookmark
plus icon
share episode

Show more best episodes

Toggle view more icon

FAQ

How many episodes does The Lancet Neurology in conversation with have?

The Lancet Neurology in conversation with currently has 182 episodes available.

What topics does The Lancet Neurology in conversation with cover?

The podcast is about Life Sciences, Health & Fitness, Sleep, Cerebral, Alzheimer'S, Medicine, Podcasts, Science and Epilepsy.

What is the most popular episode on The Lancet Neurology in conversation with?

The episode title 'Adrian Owen on detecting awareness after acute brain injury' is the most popular.

What is the average episode length on The Lancet Neurology in conversation with?

The average episode length on The Lancet Neurology in conversation with is 13 minutes.

How often are episodes of The Lancet Neurology in conversation with released?

Episodes of The Lancet Neurology in conversation with are typically released every 30 days.

When was the first episode of The Lancet Neurology in conversation with?

The first episode of The Lancet Neurology in conversation with was released on Dec 17, 2007.

Show more FAQ

Toggle view more icon

Comments